Your browser doesn't support javascript.
loading
Response to "NGS, the New Global Standard?"
Ou, Sai-Hong Ignatius; Hong, Jin-Liern; Christopoulos, Petros; Lin, Huamao M; Vincent, Sylvie; Churchill, Eric N; Soeda, Junpei; Kazdal, Daniel; Thomas, Michael; Stenzinger, Albrecht.
Afiliação
  • Ou SI; Division of Hematology-Oncology, Department of Internal Medicine, University of California Irvine School of Medicine, Orange, California. Electronic address: siou@uci.edu.
  • Hong JL; Global Evidence and Outcomes Oncology, Takeda Development Center Americas, Inc., Lexington, Massachusetts.
  • Christopoulos P; Department of Thoracic Oncology, Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany; Member of the German Center for Lung Research (DZL), Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg, Germany.
  • Lin HM; Global Evidence and Outcomes Oncology, Takeda Development Center Americas, Inc., Lexington, Massachusetts.
  • Vincent S; Oncology Therapeutic Area Unit, Takeda Development Center Americas, Inc., Lexington, Massachusetts.
  • Churchill EN; Global Medical Affairs Oncology, Takeda Pharmaceuticals USA, Inc., Lexington, Massachusetts.
  • Soeda J; Japan Medical Affairs, Japan Oncology Business Unit, Takeda Pharmaceutical Company Ltd., Tokyo, Japan.
  • Kazdal D; Member of the German Center for Lung Research (DZL), Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg, Germany; Center for Molecular Pathology (CMP), Institute of Pathology Heidelberg (IPH), University Hospital Heidelberg, Heidelberg, Germany.
  • Thomas M; Member of the German Center for Lung Research (DZL), Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg, Germany; Department of Internal Oncology of Thoracic Tumors, Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany.
  • Stenzinger A; Member of the German Center for Lung Research (DZL), Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg, Germany; Center for Molecular Pathology (CMP), Institute of Pathology Heidelberg (IPH), University Hospital Heidelberg, Heidelberg, Germany.
J Thorac Oncol ; 18(10): e116-e118, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37758351

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article